Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells

Amy M. Munchhof, Fang Li, Hilary A. White, Laura E. Mead, Theresa R. Krier, Amy Fenoglio, Xiaohong Li, Jin Yuan, Feng Chun Yang, David Ingram

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Genetic inactivation of tumor suppressor genes initiates human cancers. However, interaction of accessory cells with the tumor-initiating cell within the microenvironment is often required for tumor progression. This paradigm is relevant to understanding neurofibroma development in neurofibromatosis type I patients. Somatic inactivation of the Nf1 tumor suppressor gene, which encodes neurofibromin, is necessary but not sufficient to initiate neurofibroma development. In contrast, neurofibromas occur with high penetrance in mice in which Nf1 is ablated in Schwann cells in the context of a heterozygous mutant (Nf1+/-) microenvironment. Neurofibromas are highly vascularized, and recent studies suggest that Nf1+/- mice have increased angiogenesis in vivo. However, the function of neurofibromin in human endothelial cells (ECs) and the biochemical mechanism by which neurofibromin regulates neoangiogenesis are not known. Utilizing Nf1+/- mice, primary human ECs and endothelial progenitor cells harvested from NF1 patients, we identified a discrete Ras effector pathway, which alters the proliferation and migration of neurofibromin-deficient ECs in response to neurofibroma-derived growth factors both in vitro and in vivo. Thus, these studies identify a unique biochemical pathway in Nf1+/- ECs as a potential therapeutic target in the neurofibroma microenvironment.

Original languageEnglish
Pages (from-to)1858-1869
Number of pages12
JournalHuman Molecular Genetics
Volume15
Issue number11
DOIs
StatePublished - Jun 2006

Fingerprint

Neurofibromin 1
Neurofibroma
Intercellular Signaling Peptides and Proteins
Endothelial Cells
Tumor Suppressor Genes
Cellular Microenvironment
Neurofibromatosis 1
Neoplastic Stem Cells
Penetrance
Schwann Cells
Cell Communication
Neoplasms

ASJC Scopus subject areas

  • Genetics

Cite this

Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. / Munchhof, Amy M.; Li, Fang; White, Hilary A.; Mead, Laura E.; Krier, Theresa R.; Fenoglio, Amy; Li, Xiaohong; Yuan, Jin; Yang, Feng Chun; Ingram, David.

In: Human Molecular Genetics, Vol. 15, No. 11, 06.2006, p. 1858-1869.

Research output: Contribution to journalArticle

Munchhof, Amy M. ; Li, Fang ; White, Hilary A. ; Mead, Laura E. ; Krier, Theresa R. ; Fenoglio, Amy ; Li, Xiaohong ; Yuan, Jin ; Yang, Feng Chun ; Ingram, David. / Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. In: Human Molecular Genetics. 2006 ; Vol. 15, No. 11. pp. 1858-1869.
@article{51f307579d4c45ff94552feb19001d0f,
title = "Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells",
abstract = "Genetic inactivation of tumor suppressor genes initiates human cancers. However, interaction of accessory cells with the tumor-initiating cell within the microenvironment is often required for tumor progression. This paradigm is relevant to understanding neurofibroma development in neurofibromatosis type I patients. Somatic inactivation of the Nf1 tumor suppressor gene, which encodes neurofibromin, is necessary but not sufficient to initiate neurofibroma development. In contrast, neurofibromas occur with high penetrance in mice in which Nf1 is ablated in Schwann cells in the context of a heterozygous mutant (Nf1+/-) microenvironment. Neurofibromas are highly vascularized, and recent studies suggest that Nf1+/- mice have increased angiogenesis in vivo. However, the function of neurofibromin in human endothelial cells (ECs) and the biochemical mechanism by which neurofibromin regulates neoangiogenesis are not known. Utilizing Nf1+/- mice, primary human ECs and endothelial progenitor cells harvested from NF1 patients, we identified a discrete Ras effector pathway, which alters the proliferation and migration of neurofibromin-deficient ECs in response to neurofibroma-derived growth factors both in vitro and in vivo. Thus, these studies identify a unique biochemical pathway in Nf1+/- ECs as a potential therapeutic target in the neurofibroma microenvironment.",
author = "Munchhof, {Amy M.} and Fang Li and White, {Hilary A.} and Mead, {Laura E.} and Krier, {Theresa R.} and Amy Fenoglio and Xiaohong Li and Jin Yuan and Yang, {Feng Chun} and David Ingram",
year = "2006",
month = "6",
doi = "10.1093/hmg/ddl108",
language = "English",
volume = "15",
pages = "1858--1869",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells

AU - Munchhof, Amy M.

AU - Li, Fang

AU - White, Hilary A.

AU - Mead, Laura E.

AU - Krier, Theresa R.

AU - Fenoglio, Amy

AU - Li, Xiaohong

AU - Yuan, Jin

AU - Yang, Feng Chun

AU - Ingram, David

PY - 2006/6

Y1 - 2006/6

N2 - Genetic inactivation of tumor suppressor genes initiates human cancers. However, interaction of accessory cells with the tumor-initiating cell within the microenvironment is often required for tumor progression. This paradigm is relevant to understanding neurofibroma development in neurofibromatosis type I patients. Somatic inactivation of the Nf1 tumor suppressor gene, which encodes neurofibromin, is necessary but not sufficient to initiate neurofibroma development. In contrast, neurofibromas occur with high penetrance in mice in which Nf1 is ablated in Schwann cells in the context of a heterozygous mutant (Nf1+/-) microenvironment. Neurofibromas are highly vascularized, and recent studies suggest that Nf1+/- mice have increased angiogenesis in vivo. However, the function of neurofibromin in human endothelial cells (ECs) and the biochemical mechanism by which neurofibromin regulates neoangiogenesis are not known. Utilizing Nf1+/- mice, primary human ECs and endothelial progenitor cells harvested from NF1 patients, we identified a discrete Ras effector pathway, which alters the proliferation and migration of neurofibromin-deficient ECs in response to neurofibroma-derived growth factors both in vitro and in vivo. Thus, these studies identify a unique biochemical pathway in Nf1+/- ECs as a potential therapeutic target in the neurofibroma microenvironment.

AB - Genetic inactivation of tumor suppressor genes initiates human cancers. However, interaction of accessory cells with the tumor-initiating cell within the microenvironment is often required for tumor progression. This paradigm is relevant to understanding neurofibroma development in neurofibromatosis type I patients. Somatic inactivation of the Nf1 tumor suppressor gene, which encodes neurofibromin, is necessary but not sufficient to initiate neurofibroma development. In contrast, neurofibromas occur with high penetrance in mice in which Nf1 is ablated in Schwann cells in the context of a heterozygous mutant (Nf1+/-) microenvironment. Neurofibromas are highly vascularized, and recent studies suggest that Nf1+/- mice have increased angiogenesis in vivo. However, the function of neurofibromin in human endothelial cells (ECs) and the biochemical mechanism by which neurofibromin regulates neoangiogenesis are not known. Utilizing Nf1+/- mice, primary human ECs and endothelial progenitor cells harvested from NF1 patients, we identified a discrete Ras effector pathway, which alters the proliferation and migration of neurofibromin-deficient ECs in response to neurofibroma-derived growth factors both in vitro and in vivo. Thus, these studies identify a unique biochemical pathway in Nf1+/- ECs as a potential therapeutic target in the neurofibroma microenvironment.

UR - http://www.scopus.com/inward/record.url?scp=33744722469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744722469&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddl108

DO - 10.1093/hmg/ddl108

M3 - Article

C2 - 16648142

AN - SCOPUS:33744722469

VL - 15

SP - 1858

EP - 1869

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 11

ER -